Peregrine Pharmaceuticals (NASDAQ:PPHM)

CAPS Rating: 2 out of 5

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.

Recs

0
Player Avatar OklaBoston (68.01) Submitted: 12/5/2012 5:01:05 PM : Outperform Start Price: $1.24 PPHM Score: -9.64

Not much insider trading lately but the most recent was a buy by a director. Charts look very bottomy as well.

Member Avatar OklaBoston (68.01) Submitted: 1/11/2013 5:22:04 PM
Recs: 0

No insider sales for TWO YEARS!

Featured Broker Partners


Advertisement